OHE is coming to the US.
Following sell-out events in Europe, OHE is bringing its Pricing and Reimbursement Masterclass to the US in 2020. Reserve your place now and join us as OHE’s world-class experts and industry insiders address some of the most critical issues facing the pharmaceutical industry today including: Price Transparency, Indication-Based Pricing, Paying for Cures and Outcomes-Based Contracting. Scroll down for details on each event.
As the world’s oldest and most well-respected health economic research institute, we’re uniquely placed to bring you the latest in research, expertise and real-world evidence, as well as first-hand advice from leading experts. Together we can improve decisions surrounding healthcare, and deliver better outcomes for patients, payers and industry.
Get access to the latest research and insights, discuss these mission critical issues with OHE’s thought leaders, and share perspectives with industry peers as OHE brings the Pricing and Reimbursement Masterclass to Washington D.C. February 11-13, 2020.
Booking is opening 3 January. We are offering a multi-buy discount to anyone booking to attend more than one event in the Series: 1= $1,500, 2= $2,500, 3= $3,000.
Numbers are strictly limited to ensure that the Masterclasses remain collaborative platforms where open and transformational conversations can take place. Book now
Price Transparency: Reasserting the Role of Value-Based Pricing
11 February 2020 | Washington, D.C.
One answer to growing medicine expenditure has been a push for transparency in pricing. Our experts aren’t convinced it’s the right response. Join them as they uncover the impact of transparency on access to new technologies, and put forward some alternative approaches.
Novel Pricing Models: Indication-Based and Outcomes-Based Pricing
12 February 2020 | Washington, D.C.
Traditionally, drugs have a uniform price but in a world with significant uncertainty, multiple indications, adaptive pathways, and high-cost, high-value treatments this approach is suboptimal. Novel approaches such as Indication-Based Pricing and Outcomes-Based Contracting provide a win for patients through faster and wider access to innovative therapies, a win for payers through value for money and budget management, and a win for industry with rewards for innovation. Join us as OHE’s thought leaders present the latest research on the theory, the reality, and the narrative for convincing stakeholders to adopt flexible pricing models.
Paying for Cures: Delivering Access to Breakthrough Therapies
13 February | Washington, D.C.
There are more breakthrough therapies than ever before, many are potential cures, but strained healthcare systems are finding it increasingly difficult to afford such high-cost treatments. Join us to discuss the key challenges they’re facing – as well as the best ways to solve them.
100% of US attendees of the Pricing and Reimbursement Series said that they would recommend our Masterclasses – here’s what they’ve said:
“Excellent exploration of a complex issue, with good balance of the theory and the practice.”
“Overall a well-rounded course. The course provided an in-depth understanding of the challenge ahead of curative medicines."
"Highlighted all of the challenges and the various viewpoints. A realistic view of current and emerging situation.“
“Very comprehensive deep dive into the issues and reason for OHE recommendations.”
“A very helpful event with some very high level experts covering subjects which could be difficult and contentious. Light into informational darkness.”
About OHE Masterclass Series
Each event in our Masterclass Series provides a highly collaborative space guided by candid expert perspectives. During the event we encourage open discussion of the topic, and believe that through this we have the potential to unlock transformative insight and reveal solutions to the challenges we face every day.
As the world’s oldest and most well-respected health economic research institute, we’re uniquely placed to bring you the latest in research, expertise and real-world evidence, as well as first-hand advice from global thought leaders. Together we can improve decisions surrounding healthcare, and deliver better outcomes for patients, payers and industry.
UK 2020 Masterclass Series Theme
Demonstrating Value: evolving with innovation explores this lively technical and policy debate where the evolving and sometimes challenging nature of innovative interventions is not always matched by value assessment paradigms applied by country decision makers.
Value assessments are necessary to ensure that healthcare expenditure is optimal but there is a need for a common understanding of what constitutes value, capturing what matters most to patients, society, and payers. The 2020 Masterclass Series will take attendees through the journey of exploring value from different perspectives and providing tools to identify consolidated and novel sources of value, and generate compelling evidence at different stages of the product life-cycle to demonstrate them.